Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Clin Pharmacol Ther. 2016 Jun 20;100(3):287–294. doi: 10.1002/cpt.401

TABLE 3.

B4GALT2 genotype and on-treatment platelet reactivity

Cohort B4GALT2 Genotype PRU P-Value RPA P-Value
Discovery Cohort n=636 rs1061781 (c.909C>T)
    Non-carriers (n=510) 172.1±87.1 0.0077 * 33.1±23.4 0.0008 *
    Carriers (n=125) 148.7±90.0 25.2±22.6
rs1859728 (c.366G>C)
    Non-carriers (n=547) 170.6±86.6 0.0211 * 32.6±23.3 0.0046 *
    Carriers (n=86) 147.0±96.1 24.9±23.0
rs1061781 (c.909C>T)
    C/C (n=510) 172.1±87.1 0.034 33.1±23.4 0.0028
    C/T (n=120) 148.2±90.7 25.2±22.5
    T/T (n=5) 159.4±79.3 25.2±26.1
rs1859728 (c.366G>C)
    G/G (n=547) 170.6±86.6 0.0352 32.6±23.3 0.0134
    G/C (n=83) 148.3±97.1 25.2±23.2
    C/C (n=3) 110.4±57.2 17.6±14.7

Replication Cohort n=160 rs1061781 (c.909C>T)
    Non-carriers (n=140) 233.5±17.2 0.0001 * ND ND
    Carriers (n=20) 142.6±42.2 ND
rs1859728 (c.366G>C)
    Non-carriers (n=147) 225.7±16.9 0.0740 * ND ND
    Carriers (n=13) 181.4±76.3 ND

ND: Not determined; PRU: P2Y12 reaction units; RPA: residual platelet aggregation.

*

P-value using t-test.

P-value using Kruskal-Wallis one-way analysis of variance.

Platelet reactivity in the replication cohort was only measured by the VerifyNow™ P2Y12 assay, and genotype association with PRU was not performed due to the limited number of homozygous variant carriers.